APA

Tan D., Teoh G., Lau L. C., Lim A., Lim T. H., Yap K. C., Premalatha P., Lao Z. T., Wee N., Choo C., Wee H. C., Su S., Lee Y. S., Lee L. H., Hwang W. & Goh Y. T. (20101012). An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era. : American journal of hematology.

Chicago

Tan Daryl, Teoh Gerrard, Lau L C, Lim Alvin, Lim T H, Yap K C, Premalatha P, Lao Z T, Wee Nelson, Choo Christine, Wee H C, Su S, Lee Y S, Lee L H, Hwang William and Goh Y T. 20101012. An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era. : American journal of hematology.

Harvard

Tan D., Teoh G., Lau L. C., Lim A., Lim T. H., Yap K. C., Premalatha P., Lao Z. T., Wee N., Choo C., Wee H. C., Su S., Lee Y. S., Lee L. H., Hwang W. and Goh Y. T. (20101012). An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era. : American journal of hematology.

MLA

Tan Daryl, Teoh Gerrard, Lau L C, Lim Alvin, Lim T H, Yap K C, Premalatha P, Lao Z T, Wee Nelson, Choo Christine, Wee H C, Su S, Lee Y S, Lee L H, Hwang William and Goh Y T. An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era. : American journal of hematology. 20101012.